SCHOTT Pharma AG & Co. KGaA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE000A3ENQ51
EUR
13.50
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Sep'25
Sep'24
Dec'23
Sep'23
Dec'22
Sep'22
Sep'21
Net Sales
986.21
957.09
899.00
898.60
821.00
821.14
648.67
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
986.21
957.09
899.00
898.60
821.00
821.14
648.67
Raw Material Cost
653.75
634.48
0.00
583.53
0.00
525.88
422.50
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
254.77
238.30
0.00
1.42
0.00
1.16
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
19.75
13.19
0.00
6.94
0.00
2.43
1.45
Selling and Distribution Expenses
129.88
124.48
0.00
122.09
0.00
110.21
92.01
Other Expenses
-24.66
-22.72
0.00
1.85
0.00
1.99
2.08
Total Expenditure (Excl Depreciation)
811.54
783.21
0.00
732.44
0.00
659.62
536.80
Operating Profit (PBDIT) excl Other Income
174.7
173.9
899
166.20000000000002
821
161.5
111.89999999999999
Other Income
17.71
11.79
0.00
10.72
0.00
-2.44
0.58
Operating Profit (PBDIT)
273.06
249.65
0.00
221.94
0.00
214.66
147.47
Interest
19.75
13.19
0.00
6.94
0.00
2.43
1.45
Exceptional Items
0.00
0.00
0.00
5.71
0.00
-11.57
0.00
Gross Profit (PBDT)
332.46
322.61
0.00
315.07
0.00
295.26
226.17
Depreciation
79.44
64.98
0.00
46.65
0.00
55.36
36.44
Profit Before Tax
173.87
171.48
0.00
174.06
0.00
145.30
109.58
Tax
40.77
33.63
0.00
33.87
0.00
32.44
22.12
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
146.45
149.69
152.00
151.84
0.00
125.38
100.75
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
146.45
149.69
152.00
151.84
0.00
125.38
100.75
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.53
0.66
0.00
0.09
0.00
0.47
0.41
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
146.98
150.34
152.00
151.93
0.00
125.85
101.17
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
0.0
1.0
0.0
1.0
1.0
Reserves
891.78
786.63
0.00
690.43
0.00
707.28
417.96
Earnings per share (EPS)
0.97
0.99
0.0
1.01
0.0
0.83
0.67
Diluted Earnings per share
0.97
0.99
0.0
1.01
0.0
0.83
0.67
Operating Profit Margin (Excl OI)
17.84%
18.06%
0.0%
18.31%
0.0%
19.7%
17.03%
Gross Profit Margin
25.69%
24.71%
0.0%
24.56%
0.0%
24.44%
22.51%
PAT Margin
14.85%
15.64%
16.91%
16.9%
0.0%
15.27%
15.53%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Sep 2025 is 3.04%

stock-summary

Consolidate Net Profit

YoY Growth in year ended Sep 2025 is -2.20%

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Sep 2025 is 7.31%

stock-summary

Interest

YoY Growth in year ended Sep 2025 is 49.24%

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Sep 2025 has fallen from Sep 2024

Compare Annual Results Of SCHOTT Pharma AG & Co. KGaA With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Net Sales
986.21
0
986.21
Other Operating Income
0.00
0.00
0.00
Total Operating income
986.21
0
986.21
Raw Material Cost
653.75
0
653.75
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
254.77
0
254.77
Power Cost
0
0
0.00
Manufacturing Expenses
19.75
0
19.75
Selling and Distribution Expenses
129.88
0
129.88
Other Expenses
-24.66
0.00
-24.66
Total Expenditure (Excl Depreciation)
811.54
0
811.54
Operating Profit (PBDIT) excl Other Income
174.67
0.00
174.67
Other Income
17.71
0
17.71
Operating Profit (PBDIT)
273.06
0
273.06
Interest
19.75
0
19.75
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
332.46
0
332.46
Depreciation
79.44
0
79.44
Profit Before Tax
173.87
0
173.87
Tax
40.77
0
40.77
Provisions and contingencies
0
0
0.00
Profit After Tax
146.45
0
146.45
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
146.45
0
146.45
Share in Profit of Associates
0
0
0.00
Minority Interest
0.53
0
0.53
Other related items
0.00
0.00
0.00
Consolidated Net Profit
146.98
0
146.98
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
891.78
0
891.78
Earnings per share (EPS)
0.97
0
0.97
Diluted Earnings per share
0.97
0
0.97
Operating Profit Margin (Excl OI)
17.84%
0%
0.00
17.84%
Gross Profit Margin
25.69%
0%
0.00
25.69%
PAT Margin
14.85%
0%
0.00
14.85%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 98.62 Million
in Sep 2025

Figures in Million
stock-summary

YoY Growth in year ended Sep 2025 is 3.04%

Annual - Consolidate Net Profit
Consolidate Net Profit 14.70 Million
in Sep 2025

Figures in Million
stock-summary

YoY Growth in year ended Sep 2025 is -2.20%

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 25.53 Million
in Sep 2025

Figures in Million
stock-summary

YoY Growth in year ended Sep 2025 is 7.31%

Annual - Interest
Interest 1.97 Million
in Sep 2025

Figures in Million
stock-summary

YoY Growth in year ended Sep 2025 is 49.24%

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.84%
in Sep 2025

Figures in %
stock-summary

YoY Growth in year ended Sep 2025 has fallen from Sep 2024